The Investor Relations website contains information about Catalyst Pharmaceutical's business for stockholders, potential investors, and financial analysts.
Our company is committed to developing novel, safe, and efficacious therapies to improve the lives of people with rare diseases.
Find the latest institutional holdings data for Catalyst Pharmaceuticals, Inc. Common Stock (CPRX) including shareholders, ownership summaries, ...
May 26, 2022 · Seeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects.
Missing: relations | Show results with:relations
Discover real-time Catalyst Pharmaceuticals, Inc. Common Stock (CPRX) stock prices, quotes, historical data, news, and Insights for informed trading and ...
Rating
(6,975)
Catalyst Pharma (CPRX) will release its next earnings report on May 7, 2024. In the last quarter Catalyst Pharma reported $0.265 EPS in relation to $0.31 ...
VP & Head of Investor Relations, --, --, --. Mr. Brian Elsbernd J.D., Chief Compliance Officer & Chief Legal Officer, 311.42k, --, 1964. Mr. Pete Curry Sr. Vice ...